904 related articles for article (PubMed ID: 15212560)
1. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
Perry CM; Scott LJ
Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
[TBL] [Abstract][Full Text] [Related]
2. Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin.
Guay DR
Clin Ther; 2002 Apr; 24(4):473-89. PubMed ID: 12017394
[TBL] [Abstract][Full Text] [Related]
3. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
Scott LJ; Ormrod D; Goa KL
Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
[TBL] [Abstract][Full Text] [Related]
4. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
Wiseman LR; Benfield P
Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
[TBL] [Abstract][Full Text] [Related]
5. Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
Barriere SL
Ann Pharmacother; 1993 Sep; 27(9):1082-9. PubMed ID: 8219444
[TBL] [Abstract][Full Text] [Related]
6. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
Sader HS; Jones RN
Expert Rev Anti Infect Ther; 2007 Feb; 5(1):29-43. PubMed ID: 17266451
[TBL] [Abstract][Full Text] [Related]
7. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
Fulton B; Perry CM
Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
Croom KF; Goa KL
Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
[TBL] [Abstract][Full Text] [Related]
9. Cefdinir: an expanded-spectrum oral cephalosporin.
Guay DR
Ann Pharmacother; 2000 Dec; 34(12):1469-77. PubMed ID: 11144705
[TBL] [Abstract][Full Text] [Related]
10. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Perry CM; Brogden RN
Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin. A review of its use in paediatric infectious diseases.
Langtry HD; Balfour JA
Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
[TBL] [Abstract][Full Text] [Related]
12. Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
Wiseman LR; Balfour JA
Drugs; 1994 May; 47(5):784-808. PubMed ID: 7520858
[TBL] [Abstract][Full Text] [Related]
13. Cefditoren in vitro activity and spectrum: a review of international studies using reference methods.
Jones RN; Pfaller MA; Jacobs MR; Appelbaum PC; Fuchs PC
Diagn Microbiol Infect Dis; 2001; 41(1-2):1-14. PubMed ID: 11687308
[TBL] [Abstract][Full Text] [Related]
14. Spotlight on cefditoren pivoxil in bacterial infections.
Wellington K; Curran MP
Treat Respir Med; 2005; 4(2):149-52. PubMed ID: 15813670
[TBL] [Abstract][Full Text] [Related]
15. Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002).
Sader HS; Fritsche TR; Mutnick AH; Jones RN
Diagn Microbiol Infect Dis; 2003 Nov; 47(3):515-25. PubMed ID: 14596971
[TBL] [Abstract][Full Text] [Related]
16. Cefditoren pivoxil.
Darkes MJ; Plosker GL
Drugs; 2002; 62(2):319-36; discussion 337-8. PubMed ID: 11817976
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin: an updated review of its use in the treatment of bacterial infections.
Hurst M; Lamb HM; Scott LJ; Figgitt DP
Drugs; 2002; 62(14):2127-67. PubMed ID: 12269858
[TBL] [Abstract][Full Text] [Related]
18. Cefditoren pivoxil: a review of its use in the treatment of bacterial infections.
Wellington K; Curran MP
Drugs; 2004; 64(22):2597-618. PubMed ID: 15516158
[TBL] [Abstract][Full Text] [Related]
19. Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.
Easton J; Noble S; Perry CM
Drugs; 2003; 63(3):311-40. PubMed ID: 12534334
[TBL] [Abstract][Full Text] [Related]
20. Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
Brogden RN; McTavish D
Drugs; 1993 May; 45(5):716-36. PubMed ID: 7686466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
